A study by Yale School of Medicine reveals that survival rates for patients with a thoracic aneurysm are significantly better, and complications are fewer, among patients who take statin cholesterol drugs than those who do not. The study appears in the American Journal of Cardiology.
- Event - Oct 22 UCLA Hammer Museum’s annual Gala in the Garden raises a record $2.5 million
- Medicine - Oct 22 UW to serve as national hub for mentor training as part of diversity consortium
- Architecture - Oct 22 Hashim Sarkis named dean of the School of Architecture and Planning
- Administration - Oct 22 Mission Big Red Flag: Simulated flight, real sweat
- Medicine - Oct 22 U-M chemist receives $2M to map disease- causing ’free radical’ damage
- Careers - Oct 22 Senate to discuss undergraduate education and alternative careers for PhDs
- Social Sciences - Oct 22 Stanford psychologist explores how meaningfulness cultivates well- being over time
- Earth Sciences - Oct 22 Researchers resolve the Karakoram glacier anomaly, a cold case of climate science
- Study of Religions - Oct 22 Corber, Winsor to receive honorary degrees
- Agronomy - Oct 22 USDA designates Cornell as obesity prevention hub
- Administration - Oct 22 University mourns death of senior Ilan Rasooly
- Environmental Sciences - Oct 22 Auto companies continue to exceed fuel economy standards
Statins may protect against death from aneurysm, Yale study finds
An aneurysm is a swelling of an artery, and is a common cause of death. It’s usually asymptomatic, with death or a life-threatening complication such as rupture or dissection being the first manifestation. Statins are cholesterol-lowering drugs that are widely used in patients with cardiovascular disease.
Assistant professor of cardiothoracic surgery Ion S. Jovin, M.D., and colleagues studied 649 patients with thoracic aortic aneurysms: 147 were taking statins and 502 were not. In long-term follow-up 80% of those taking statins survived, compared with 67% percent of those not taking statins. In addition, a smaller percentage of those taking statins suffered a rupture or dissection (splitting of the aorta), compared to those who were not taking statins.
"The intake of statins was associated with an improvement in long-term outcomes among these patients," said co-author John Elefteriades, M.D., professor of cardiothoracic surgery at Yale School of Medicine and director of the Aortic Institute at Yale-New Haven Hospital. "In addition to better survival, fewer patients taking statins required surgical intervention," Elefteriades added.
Medical science has searched for decades for a medicine that could treat aneurysm disease, with little success. The current standard therapy is to keep blood pressure low to discourage rupture of the enlarged artery. Jovin said his research suggests that "statins could offer a significant protective effect to patients at risk of death or complications from aneurysm disease. However, the ultimate proof would be a randomized clinical trial." Elefteriades adds, "We now have some arrows in our quiver of medicines to treat this disease."
Other authors are Mona Duggal, Keita Ebisu, Hyung Paek, A. Dana Oprea, Maryann Tranquilli, John Rizzo, Redin Memet, Marina Feldman, James Dziura, and Cynthia A. Brandt of Yale.
Last job offers
- Microtechnics - 22.10
Materials Science Engineering & Mechanical Engineering - Assistant Professor (AA8844)
- Administration - 22.10
Associate Professor & Chair, Public Administration
- Medicine - 22.10
Assistant Professor - Kinesiology and Nutrition
- Astronomy - 21.10
Aeronautics and Astronautics - Assistant or Associate Professor (AA8746)
- Pedagogy - 21.10
Assistant, Associate, or Full Professor - Finance Fall 2015
- Arts - 21.10
Assistant Professor - Popular Music and Media Studies
- Arts - 21.10
Assistant Professor - Ethnomusicology
- Computer Science - 21.10
Asst/Assoc/Prof, Library and Info Scienc